A unique collaboration among physician-scientists at Memorial Sloan-Kettering Cancer Center (MSKCC) has yielded the most comprehensive genomic analysis of prostate cancer to date. "Genomic studies in other cancer types have resulted in new drug targets and strategies to classify patients into clinically meaningful subgroups that improve treatment decisions," said senior study author Charles Sawyers, Chair of the Human Oncology and Pathogenesis Program at MSKCC and a HHMI investigator. "This first -ever database of its type brings us one step closer to achieving that goal in prostate cancer."

International team of Italy-US scientists reports discovery of a new mechanism of avian influenza virus circulation and transmission in nature

Why are tropical forests so biologically rich? Smithsonian researchers have new evidence that the answer to one of life's great unsolved mysteries lies underground, according to a study published in the journal, Nature.